Dogs have become important partners in cancer research | Let consumers know their drugs have undergone animal testing | View FBR's list of medications that were advanced by animal testing
January 17, 2018
FBR Smartbrief
Top Story
Dogs have become important partners in cancer research
Dogs have become important partners in cancer research
Dogs and people are prone to many of the same cancers, and clinical trials conducted in canine patients may ultimately benefit both, researchers say. Pet dogs are excellent cancer avatars not only because of their genetic similarity to people, but also because they live in the same environments we do, notes veterinarian and oncologist Douglas Thamm.
American Veterinarian (1/17) 
LinkedIn Twitter Facebook Google+ Email
Let consumers know their drugs have undergone animal testing
Nearly every approved drug is tested on animals at some point in development, and product labels that reflect this fact could raise the public's appreciation of animal research, writes postdoctoral fellow Shaun Khoo. Labels that note animal testing would enhance discussions about the ethical use of animals and would allow consumers to decide whether the benefits of a given treatment outweigh any perceived ethical cost, Khoo writes.
The Scientist online (1/16) 
LinkedIn Twitter Facebook Google+ Email
Research Breakthroughs
Experimental TB vaccine shows promise in nonhuman primates
An experimental cytomegalovirus-based tuberculosis vaccine reduced or prevented infection in 70% of rhesus macaques exposed to a virulent strain of the virus a year after inoculation, researchers reported in Nature Medicine. About 40% of the macaques showed no sign of infection, and 30% developed a comparatively mild infection.
The Oregonian (Portland) (1/15) 
LinkedIn Twitter Facebook Google+ Email
Experimental compound suppresses HIV in mice, enhances potency of other drugs
An experimental drug suppressed HIV to undetectable levels, protected immune cells and worked synergistically with existing HIV treatments in HIV-infected mice with transplanted human blood cells. The research is published in Proceedings of the National Academy of Sciences.
Connecticut Post (Fairfield County-Bridgeport) (1/8) 
LinkedIn Twitter Facebook Google+ Email
Study of opossums yields insights into human miscarriage
Study of opossums yields insights into human miscarriage
(Johan Ordonez/AFP/Getty Images)
A study of opossums, rabbits, armadillos and hyraxes showed that placental mammals evolved to mute an inflammatory response to an egg implanting in the placenta, thus enabling extended gestation. Decidual cells, which form in the uterine lining early in pregnancy, persist through delivery in mice and humans but disappear quickly in many other placental mammals, suggesting that cells might moderate the inflammatory response and result in miscarriage if the process goes awry.
Science (free content) (1/10) 
LinkedIn Twitter Facebook Google+ Email
Other News
Animal Health
Lab mouse space guidelines might not have much effect on welfare
Many countries specify minimum space allowances and other requirements for laboratory mice, but the guidelines are often based on common practice instead of evidence, and a study published in Scientific Reports found that space allowance has little effect on lab mouse health. Other studies have found that shelter and nesting material more strongly affected mouse welfare than the provision of extra space, and future studies should investigate the effects of floor area and group size along with structural enrichment, writes researcher Jeremy Bailoo.
Speaking of Research (1/15) 
LinkedIn Twitter Facebook Google+ Email
Aquariums collecting data on dolphins, whales to improve habitats
Eight bottlenose dolphins at Brookfield Zoo near Chicago have been outfitted with activity monitors that record speed and acceleration, distance traveled and location, among other data, and the study will be expanded. The Institute of Museum and Library Services issued a $740,000 grant to use the sensors to collect data on nearly 300 dolphins and 20 beluga whales at 44 institutions in seven countries to inform facility design, training programs and more.
WTTW-TV (Chicago, Ill.) (1/11) 
LinkedIn Twitter Facebook Google+ Email
Other News
FBR in the News
FBR president: Cherry-picked TB study is an outlier
An investigation published in The BMJ showed that researchers misrepresented the results of animal studies on a tuberculosis vaccine so that clinical trials could advance, but critics of animal research who are pointing to the episode as justification are wrong, says FBR President Matthew R. Bailey. "Animal research clearly has had a critical role in the 53 million lives saved from tuberculosis since 2000, in large part because of vaccines," Bailey said. "Animal research continues to yield extremely important safety and efficacy data, which is why regulatory bodies around the world require it."
ALN Magazine online (1/16) 
LinkedIn Twitter Facebook Google+ Email
FBR News
Donate to FBR
For 35 years, FBR has advanced biomedical research for the sake of both human and animal health. We can't do our job without your support. Please give what you can. Together we will continue to make a difference.
LinkedIn Twitter Facebook Google+ Email
It is impossible to live without failing at something, unless you live so cautiously that you might as well not have lived at all -- in which case, you fail by default.
J.K. Rowling,
LinkedIn Twitter Facebook Google+ Email
Learn more about FBR:
About FBR | Donate
About FBR
The Foundation for Biomedical Research (FBR) is the nation’s oldest and largest non-profit dedicated to improving human and animal health by promoting public understanding and support for biomedical research. Our mission is to educate people about the essential role animal research plays in the quest for medical advancements, treatments and cures for both people and animals.
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2018 SmartBrief, Inc.®
Privacy policy |  Legal Information